140350_CD
pp70-81_JJ
27_CD
2_CD
03_CD
8:42_CD
pm_NN
Page_NN
78_CD
REED_NN
ELSEVIER_NN
NV_NN
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
1_CD
Operating_GER
loss_NN
Operating_GER
loss_NN
is_VPRT [PASS]
stated_VBN [PUBV]
after_IN
the_DT
gross_JJ
remuneration_NOMZ
for_PIN
present_JJ
and_PHC
former_JJ
directors_NN
of_PIN
Reed_NN
Elsevier_NN
NV_NN
in_PIN
respect_NN
of_PIN
services_NN
rendered_VBN [WZPAST]
to_PIN
Reed_NN
Elsevier_NN
NV_NN
and_CC
the_DT
combined_JJ
businesses_NOMZ
._.
Fees_NN
for_PIN
members_NN
of_PIN
the_DT
supervisory_JJ
board_NN
of_PIN
Reed_NN
Elsevier_NN
NV_NN
of_PIN
0.1_CD
m_NN [BEMA]
2001_CD
:_:
0.2_CD
m_NN
are_VPRT [PASS]
included_VBN
in_PIN
gross_JJ
remuneration_NOMZ
._.
In_PIN
so_RB
far_PLACE
as_IN
gross_JJ
remuneration_NOMZ
is_VPRT [PASS]
related_VBN
to_PIN
services_NN
rendered_VBN [WZPAST]
to_PIN
Reed_NN
Elsevier_NN
Group_NN
plc_NN
and_PHC
Elsevier_NN
Reed_NN
Finance_NN
BV_NN
,_,
it_PIT
is_VPRT [BYPA]
borne_VBN
by_PIN
these_DEMO
companies_NN
._.
2_CD
Net_JJ
interest_NN
2002_CD
2001_CD
m_NN
m_NN
Interest_NN
on_PIN
receivables_NN
from_PIN
joint_JJ
ventures_NN
3_CD
6_CD
Other_JJ
interest_NN
4_CD
57_CD
Net_JJ
interest_NN
income_NN
7_CD
63_CD
3_CD
Adjusted_VBN
figures_NN
Adjusted_JJ
profit_NN
and_PHC
cash_NN
flow_NN
figures_NN
are_VPRT [PASS]
used_VBN
as_IN
additional_JJ
performance_NN
measures_NN
._.
The_DT
adjusted_JJ
figures_NN
are_VPRT [PASS]
derived_VBN
as_IN
follows_VPRT
:_:
2002_CD
2001_CD
m_NN
m_NN
Profit_NN
before_IN
tax_NN
230_CD
221_CD
Adjustments_NOMZ
:_:
Amortisation_NOMZ
of_PIN
goodwill_NN
and_CC
intangible_JJ
assets_NN
419_CD
403_CD
Exceptional_JJ
items_NN
88_CD
59_CD
Adjusted_JJ
profit_NN
before_IN
tax_NN
737_CD
683_CD
Profit_NN
attributable_JJ
to_PIN
ordinary_JJ
shareholders_NN
144_CD
101_CD
Adjustments_NOMZ
:_:
Amortisation_NOMZ
of_PIN
goodwill_NN
and_CC
intangible_JJ
assets_NN
407_CD
408_CD
Exceptional_JJ
items_NN
9_CD
6_CD
Adjusted_JJ
profit_NN
attributable_JJ
to_PIN
ordinary_JJ
shareholders_NN
542 503 2002 2001_CD
Earnings_GER
per_PIN
ordinary_JJ
share_NN
0.18_CD
0.13_CD
Adjustments_NOMZ
:_:
Amortisation_NOMZ
of_PIN
goodwill_NN
and_CC
intangible_JJ
assets_NN
0.52_CD
0.52_CD
Exceptional_JJ
items_NN
0.01_CD
0.01_CD
Adjusted_VBN
earnings_GER
per_PIN
ordinary_JJ
share_NN
0.69_CD
0.64_CD
4_CD
Fixed_VBN
assets_NN
Investments_NOMZ
in_PIN
joint_JJ
ventures_NN
2002_CD
2001_CD
m_NN
m_NN [BEMA]
At_PIN
1_CD
January_NN
2,506_CD
1,674_CD
Investment_NOMZ
in_PIN
joint_JJ
venture_NN
916_CD
Share_NN
in_PIN
profits_NN
142_CD
62_CD
Dividends_NN
received_VBD
150_CD
100_CD
Currency_NN
translation_NOMZ
303_CD
42_CD
Equalisation_NOMZ
see_VB [PRIV]
note_NN
9_CD
88_CD
At_PIN
31_CD
December_NN
2,195_CD
2,506_CD
78_CD
REED_NN
ELSEVIER_NN
ANNUAL_NN
REPORTS_NN
&_CC
FINANCIAL_NN
STATEMENTS_NOMZ
2002 140350_CD
pp70-81_JJ
27_CD
2_CD
03_CD
8:42_CD
pm_NN
Page_NN
79_CD
REED_NN
ELSEVIER_NN
NV_NN
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
4_CD
Fixed_VBN
assets_NN
continued_VBD
The_DT
investment_NOMZ
in_PIN
joint_JJ
ventures_NN
comprises_VPRT
the_DT
groups_NN
share_NN
at_PIN
the_DT
following_JJ
amounts_NN
of_PIN
:_:
2002_CD
2001_CD
m_NN [PASS]
m_NN [PASS]
Fixed_VBN
assets_NN
4,925_CD
6,112_CD
Current_JJ
assets_NN
1,699_CD
1,837_CD
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
within_PIN
one_CD
year_NN
2,609_CD
3,221_CD
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
after_IN
more_EMPH
than_PIN
one_CD
year_NN
1,731_CD
2,047_CD
Provisions_NN
84_CD
171_CD
Minority_NOMZ
interests_NN
5_CD
4_CD
Total_JJ
2,195_CD
2,506_CD
The_DT
investments_NOMZ
in_PIN
joint_JJ
ventures_NN
are_VPRT
:_:
Reed_NN
Elsevier_NN
Group_NN
plc_NN
,_,
London_NN
Elsevier_NN
Reed_NN
Finance_NN
BV_NN
,_,
Amsterdam_NN
In_CONJ
addition_NULL
,_,
Reed_NN
Elsevier_NN
NV_NN
holds_VPRT [PRIV]
0.14_CD
m_JJ
par_NN
value_NN
in_PIN
shares_NN
with_PIN
special_JJ
dividend_NN
rights_NN
in_PIN
Reed_NN
Elsevier_NN
Overseas_NN
BV_NN
and_PHC
Reed_NN
Elsevier_NN
Nederland_NN
BV_NN
,_,
both_DT
with_PIN
registered_VBN
offices_NN
in_PIN
Amsterdam_NN
._.
These_DEMO
shares_NN
are_VPRT [PASS]
included_VBN
in_PIN
the_DT
amount_NN
shown_VBN [PRIV]
under_IN
investments_NOMZ
in_PIN
joint_JJ
ventures_NN
above_PLACE
._.
They_TPP3
enable_VPRT
Reed_NN
Elsevier_NN
NV_NN
to_TO
receive_VB
dividends_NN
from_PIN
companies_NN
within_PIN
the_DT
same_JJ
tax_NN
jurisdiction_NOMZ
._.
5_CD
Debtors_NN
2002_CD
2001_CD
m_NN
m_NN
Joint_NN
ventures_NN
50_CD
88_CD
Other_JJ
accounts_NN
receivable_NN
6_CD
6_CD
Total_JJ
56_CD
94_CD
The_DT
accounts_NN
receivable_NN
from_PIN
joint_JJ
ventures_NN
bear_VPRT
interest_NN
._.
6_CD
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
within_PIN
one_CD
year_NN
2002_CD
2001_CD
m_NN [PASS]
m_NN [PASS]
Proposed_VBN [SUAV]
dividend_NN
156_CD
157_CD
Taxation_NOMZ
10_CD
11_CD
Accounts_NN
payable_JJ
and_PHC
other_JJ
debts_NN
1_CD
1_CD
Total_JJ
167_CD
169_CD
7_CD
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
after_IN
more_EMPH
than_PIN
one_CD
year_NN
2002_CD
2001_CD
m_NN
m_NN
Debenture_NN
loans_NN
6_CD
5_CD
Debenture_NN
loans_NN
consist_VPRT
of_PIN
four_CD
convertible_JJ
personnel_NN
debenture_NN
loans_NN
with_PIN
a_DT
weighted_JJ
average_JJ
interest_NN
rate_NN
of_PIN
5.4_CD
%_NN
._.
Depending_VBG [PRESP]
on_PIN
the_DT
conversion_NN
terms_NN
,_,
the_DT
surrender_NN
of_PIN
227_CD
or_CC
200_CD
par_JJ
value_NN
debenture_NN
loans_NN
qualifies_VPRT
for_PIN
the_DT
acquisition_NOMZ
of_PIN
20-50_CD
Reed_NN
Elsevier_NN
NV_NN
ordinary_JJ
shares_NN
._.
REED_NN
ELSEVIER_NN
ANNUAL_NN
REPORTS_NN
&_CC
FINANCIAL_NN
STATEMENTS_NOMZ
2002 79 140350_CD
pp70-81_JJ
27_CD
2_CD
03_CD
8:42_CD
pm_NN
Page_NN
80_CD
REED_NN
ELSEVIER_NN
NV_NN
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
8_CD
Provisions_NN
2002_CD
2001_CD
m_NN [PASS]
m_NN [PASS]
Deferred_VBN
taxation_NOMZ
58_CD
58_CD
Pension_NN
1_CD
1_CD
Total_JJ
59_CD
59_CD
9_CD
Shareholders_NN
funds_NN
Share_NN
capital_NN
Paid-in_PIN
Legal_JJ
Other_JJ
issued_VBN
surplus_NN
reserves_NN
reserves_NN
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW [BEMA]
At_PIN
1_CD
January_NN
2001_CD
47_CD
1,328_CD
432_CD
641_CD
2,448_CD
Profit_NN
attributable_JJ
to_PIN
ordinary_JJ
shareholders_NN
101_CD
101_CD
Equity_NOMZ
dividends_NN
paid_VBN
and_PHC
proposed_VBN [SUAV]
221_CD
221_CD
Issue_NN
of_PIN
shares_NN
,_,
net_NN
of_PIN
expenses_NN
110_CD
110_CD
Dividends_NN
from_PIN
joint_JJ
ventures_NN
100_CD
100_CD
Exchange_NN
translation_NOMZ
differences_NN
42_CD
42_CD
Equalisation_NOMZ
adjustments_NOMZ
88_CD
88_CD
At_PIN
1_CD
January_NN
2002_CD
47_CD
1,438_CD
387_CD
520_CD
2,392_CD
Profit_NN
attributable_JJ
to_PIN
ordinary_JJ
shareholders_NN
144_CD
144_CD
Equity_NOMZ
dividends_NN
paid_VBN
and_PHC
proposed_VBN [SUAV]
221_CD
221_CD
Issue_NN
of_PIN
shares_NN
,_,
net_NN
of_PIN
expenses_NN
22_CD
22_CD
Dividends_NN
from_PIN
joint_JJ
ventures_NN
150_CD
150_CD
Exchange_NN
translation_NOMZ
differences_NN
303_CD
303_CD
At_PIN
31_CD
December_NN
2002_CD
47_CD
1,460_CD
78_CD
449_CD
2,034_CD
The_DT
authorised_JJ
share_NN
capital_NN
consists_VPRT
of_PIN
2,100_CD
m_NN [BEMA]
ordinary_JJ
shares_NN
and_CC
30m_JJ
registered_VBN
R-shares_NN
._.
The_DT
R-shares_NN
are_VPRT [BYPA]
held_VBN [PRIV]
by_PIN
a_DT
subsidiary_NN
company_NN
of_PIN
Reed_NN
Elsevier_NN
PLC._NN
._.
The_DT
R-shares_NN
are_VPRT [BEMA]
convertible_PRED
at_PIN
the_DT
election_NOMZ
of_PIN
the_DT
holder_NN
into_PIN
ten_NN
ordinary_JJ
shares_NN
each_QUAN
._.
They_TPP3
have_VPRT
otherwise_CONJ
the_DT
same_JJ
rights_NN
as_IN
the_DT
ordinary_JJ
shares_NN
,_,
except_PIN
that_DEMO
Reed_NN
Elsevier_NN
NV_NN
may_POMD
pay_VB
a_DT
lower_JJ
dividend_NN
on_PIN
the_DT
R-shares_NN
._.
Within_PIN
paid-in_PIN
surplus_NN
,_,
an_DT
amount_NN
of_PIN
1,283_CD
m_NN [BEMA]
2001_CD
:_:
1,261_CD
m_NN
is_VPRT [BEMA]
free_PRED
of_PIN
tax_NN
._.
On_PIN
31_CD
December_NN
2002_CD
,_,
there_EX
were_VBD
options_NOMZ
outstanding_JJ
for_PIN
the_DT
purchase_NN
of_PIN
32.7_CD
m_NN [BEMA]
2001_CD
:_:
28.4_CD
m_NN
shares_NN
at_PIN
an_DT
average_JJ
price_NN
of_PIN
12.36_CD
2001_CD
:_:
11.90_CD
._.
The_DT
average_JJ
term_NN
of_PIN
these_DEMO
options_NOMZ
is_VPRT [BEMA]
four_CD
years_NN
2001_CD
:_:
four_CD
years_NN
._.
10_CD
Contingent_JJ
liabilities_NOMZ
There_EX
are_VPRT
contingent_JJ
liabilities_NOMZ
in_PIN
respect_NN
of_PIN
borrowings_GER
of_PIN
the_DT
Reed_NN
Elsevier_NN
Group_NN
plc_NN
group_NN
and_CC
the_DT
Elsevier_NN
Reed_NN
Finance_NN
BV_NN
group_NN
guaranteed_VBN [PUBV] [WZPAST]
by_PIN
Reed_NN
Elsevier_NN
NV_NN
as_IN
follows_VPRT
:_:
2002_CD
2001_CD
m_NN [PASS]
m_NN [PASS]
Guaranteed_VBN [PUBV] [WZPAST]
jointly_RB
and_PHC
severally_RB
with_PIN
Reed_NN
Elsevier_NN
PLC_NN
4,493_CD
5,061_CD
Financial_NN
instruments_NOMZ
disclosures_NN
in_PIN
respect_NN
of_PIN
the_DT
borrowings_GER
covered_VBN [WZPAST]
by_PIN
the_DT
above_PLACE
guarantees_NN
are_VPRT [PASS]
given_VBN
in_PIN
note_NN
22_CD
to_PIN
the_DT
Reed_NN
Elsevier_NN
combined_VBN
financial_JJ
statements_NOMZ
on_PIN
pages_NN
47_CD
to_PIN
51_CD
._.
The_DT
financial_JJ
statements_NOMZ
were_VBD [BYPA]
signed_VBN
by_PIN
the_DT
boards_NN
of_PIN
directors_NN
,_,
19_CD
February_NN
2003_CD
._.
MTabaksblat_NN
MH_NN
Armour_NN
Chairman_NN
Chief_NN
Financial_NN
Officer_NN
80_CD
REED_NN
ELSEVIER_NN
ANNUAL_NN
REPORTS_NN
&_CC
FINANCIAL_NN
STATEMENTS_NOMZ
2002_CD
